D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 61 Citations 14,375 204 World Ranking 1927 National Ranking 813

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Surgery

Erik R. Dubberke spends much of his time researching Clostridium difficile, Intensive care medicine, Epidemiology, Internal medicine and Incidence. The study incorporates disciplines such as Young adult, Retrospective cohort study, Enterocolitis and Diarrhea in addition to Clostridium difficile. His study in Retrospective cohort study is interdisciplinary in nature, drawing from both Cohort study, Cohort and Risk factor.

His Intensive care medicine research incorporates themes from Cancer, Hepatitis C, Emergency medicine, Long-term care and Disease. His research in Epidemiology intersects with topics in Infection control, Environmental health, Acute care, Public health and Intensive care unit. The Internal medicine study which covers Surgery that intersects with Adverse effect.

His most cited work include:

  • Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) (1087 citations)
  • Recommendations for Surveillance of Clostridium difficile-Associated Disease (502 citations)
  • Burden of Clostridium difficile on the Healthcare System (404 citations)

What are the main themes of his work throughout his whole career to date?

Erik R. Dubberke focuses on Clostridium difficile, Internal medicine, Intensive care medicine, Epidemiology and Incidence. His studies in Clostridium difficile integrate themes in fields like Retrospective cohort study, Disease and Diarrhea. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Surgery.

His study looks at the relationship between Intensive care medicine and fields such as Transmission, as well as how they intersect with chemical problems. His research in Epidemiology tackles topics such as Acute care which are related to areas like Medical emergency. His research investigates the connection between Infection control and topics such as Emergency medicine that intersect with issues in Psychological intervention.

He most often published in these fields:

  • Clostridium difficile (50.66%)
  • Internal medicine (41.41%)
  • Intensive care medicine (27.31%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (41.41%)
  • Clostridioides (3.52%)
  • Antibiotics (6.61%)

In recent papers he was focusing on the following fields of study:

Internal medicine, Clostridioides, Antibiotics, Feces and Microbiome are his primary areas of study. Erik R. Dubberke has included themes like Gastroenterology and Clostridium difficile in his Internal medicine study. His Clostridium difficile research includes elements of Retrospective cohort study and Reproduction spores.

The concepts of his Clostridioides study are interwoven with issues in Epidemiology, Terminal cleaning and Intensive care medicine. His research integrates issues of Clinical epidemiology, Antimicrobial stewardship, Hand disinfection and Clostridium Infections in his study of Intensive care medicine. The Microbiome study combines topics in areas such as Antibiotic resistance, Immunology and Microbiology.

Between 2018 and 2021, his most popular works were:

  • Metabolomic networks connect host-microbiome processes to human Clostridioides difficile infections (22 citations)
  • Clostridioides (Clostridium) difficile infection burden in Japan: A multicenter prospective study. (22 citations)
  • Comparative Genomics of Antibiotic-Resistant Uropathogens Implicates Three Routes for Recurrence of Urinary Tract Infections. (19 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Surgery

His primary areas of investigation include Internal medicine, Transplantation, Feces, Clostridium difficile and Incidence. His work on Clostridioides, Clinical endpoint and Odds ratio as part of general Internal medicine study is frequently linked to Placebo-controlled study, bridging the gap between disciplines. The various areas that Erik R. Dubberke examines in his Transplantation study include Adverse effect, Fidaxomicin and Immunology.

His work carried out in the field of Feces brings together such families of science as Microbiome and Asymptomatic. His Clostridium difficile research integrates issues from Survival rate, Solid organ transplantation and Retrospective cohort study. Erik R. Dubberke combines topics linked to Cohort with his work on Incidence.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)

L Clifford McDonald;Dale N Gerding;Stuart Johnson;Stuart Johnson;Johan S Bakken.
Clinical Infectious Diseases (2018)

2323 Citations

Recommendations for Surveillance of Clostridium difficile-Associated Disease

L. Clifford McDonald;Bruno Coignard;Erik Dubberke;Xiaoyan Song.
Infection Control and Hospital Epidemiology (2007)

796 Citations

Burden of Clostridium difficile on the healthcare system.

Erik R. Dubberke;Margaret A. Olsen.
Clinical Infectious Diseases (2012)

665 Citations

Incidence of Clostridium difficile Infection in Inflammatory Bowel Disease

Joseph F. Rodemann;Erik R. Dubberke;Kimberly A. Reske;Da Hea Seo.
Clinical Gastroenterology and Hepatology (2007)

632 Citations

Strategies to Prevent Central Line-Associated Bloodstream Infections in Acute Care Hospitals

Jonas Marschall;Leonard A Mermel;David Classen;Kathleen M Arias.
Infection Control and Hospital Epidemiology (2008)

581 Citations

Clostridium difficile—Associated Disease in a Setting of Endemicity: Identification of Novel Risk Factors

Erik R. Dubberke;Kimberly A. Reske;Yan Yan;Margaret A. Olsen.
Clinical Infectious Diseases (2007)

356 Citations

Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update

Erik R. Dubberke;Philip Carling;Ruth Carrico;Curtis J. Donskey.
Infection Control and Hospital Epidemiology (2014)

331 Citations

Prevention and treatment of cancer-related infections, version 2.2016

Lindsey Robert Baden;Sankar Swaminathan;Michael Angarone;Gayle Blouin.
Journal of The National Comprehensive Cancer Network (2016)

314 Citations

Prevention and treatment of cancer-related infections

Lindsey Robert Baden;William Bensinger;Michael Angarone;Corey Casper.
Journal of The National Comprehensive Cancer Network (2012)

280 Citations

Review of current literature on the economic burden of Clostridium difficile infection.

Erik R. Dubberke;Albert I. Wertheimer.
Infection Control and Hospital Epidemiology (2009)

273 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Erik R. Dubberke

Mark H. Wilcox

Mark H. Wilcox

University of Leeds

Publications: 80

Ed J. Kuijper

Ed J. Kuijper

Leiden University Medical Center

Publications: 66

Dale N. Gerding

Dale N. Gerding

Veterans Health Administration

Publications: 62

Kevin W. Garey

Kevin W. Garey

University of Houston

Publications: 59

Thomas V. Riley

Thomas V. Riley

University of Western Australia

Publications: 57

Curtis J. Donskey

Curtis J. Donskey

Louis Stokes Cleveland VA Medical Center

Publications: 56

Vincent B. Young

Vincent B. Young

University of Michigan–Ann Arbor

Publications: 49

L. Clifford McDonald

L. Clifford McDonald

Centers for Disease Control and Prevention

Publications: 48

Stuart Johnson

Stuart Johnson

Loyola University Medical Center

Publications: 47

Herbert L. DuPont

Herbert L. DuPont

The University of Texas Health Science Center at Houston

Publications: 37

Oliver A. Cornely

Oliver A. Cornely

University of Cologne

Publications: 31

Ciaran P. Kelly

Ciaran P. Kelly

Beth Israel Deaconess Medical Center

Publications: 29

Monica A. Slavin

Monica A. Slavin

Peter MacCallum Cancer Centre

Publications: 29

Olivier Lortholary

Olivier Lortholary

Université Paris Cité

Publications: 28

Ashwin N. Ananthakrishnan

Ashwin N. Ananthakrishnan

Harvard University

Publications: 27

Patricia Muñoz

Patricia Muñoz

Hospital General Universitario Gregorio Marañón

Publications: 25

Trending Scientists

Vinod Chandran

Vinod Chandran

Queensland University of Technology

Marcello Pelillo

Marcello Pelillo

Ca Foscari University of Venice

Siu Cheung Hui

Siu Cheung Hui

Nanyang Technological University

Bong Wie

Bong Wie

Iowa State University

Mehdi Asheghi

Mehdi Asheghi

Stanford University

Elies Molins

Elies Molins

Institut de Ciència de Materials de Barcelona

Nobuo Ueno

Nobuo Ueno

Chiba University

Adriano Nunes-Nesi

Adriano Nunes-Nesi

Universidade Federal de Viçosa

Richard B. Vallee

Richard B. Vallee

Columbia University

Mark H. Kaplan

Mark H. Kaplan

University of Michigan–Ann Arbor

Andreas Wiesmann

Andreas Wiesmann

University of Bern

Keith P. Shine

Keith P. Shine

University of Reading

Holly Bridge

Holly Bridge

University of Oxford

Sonja K. Schoenwald

Sonja K. Schoenwald

Medical University of South Carolina

David Elbaz

David Elbaz

Université Paris Cité

Michael Eracleous

Michael Eracleous

Pennsylvania State University

Something went wrong. Please try again later.